U
ACHV icon

UBS’s Achieve Life Sciences ACHV Stock Holding History

UBS’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$3K Sell
1
-8
-89% -$55.6K ﹤0.01% 9761
2014
Q2 		$71K Sell
9
-3
-25% -$36.9K ﹤0.01% 6382
2014
Q1 		$301K Buy
+12
New +$295K ﹤0.01% 4759
2013
Q4 		– Hold
0
– – – 9168

Other funds holding ACHV

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

UBS's ACHV Position: Q3 2014 in Review

UBS reduced its Achieve Life Sciences (ACHV) stake by 89% in Q3 2014, selling an estimated $55.6K and leaving 1 share worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #9416.

UBS first reported a position in ACHV in Q4 2013 and has held it in 4 quarters since. The position peaked at $93K in Q1 2014. 52 funds tracked by Wall St. Rank hold ACHV as of Q3 2014.

  • UBS held 1 share of Achieve Life Sciences worth $5K as of Q3 2014.
  • UBS sold 8 Achieve Life Sciences shares in Q3 2014, an estimated $55.6K.
  • Achieve Life Sciences made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9416 holding.
  • UBS first reported a position in Achieve Life Sciences in Q4 2013 and has held it in 4 quarters since.
  • UBS's Achieve Life Sciences position peaked at $93K in Q1 2014.
  • 52 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.